DK0496135T3 - Cellefri Mareks sygdomsvirus-vaccine - Google Patents

Cellefri Mareks sygdomsvirus-vaccine

Info

Publication number
DK0496135T3
DK0496135T3 DK91203365.1T DK91203365T DK0496135T3 DK 0496135 T3 DK0496135 T3 DK 0496135T3 DK 91203365 T DK91203365 T DK 91203365T DK 0496135 T3 DK0496135 T3 DK 0496135T3
Authority
DK
Denmark
Prior art keywords
disease virus
cell
marek
virus vaccine
vaccine
Prior art date
Application number
DK91203365.1T
Other languages
English (en)
Inventor
William Baxendale
Original Assignee
Akzo Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8205666&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0496135(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Akzo Nv filed Critical Akzo Nv
Application granted granted Critical
Publication of DK0496135T3 publication Critical patent/DK0496135T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/245—Herpetoviridae, e.g. herpes simplex virus
    • A61K39/255—Marek's disease virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16311—Mardivirus, e.g. Gallid herpesvirus 2, Marek-like viruses, turkey HV
    • C12N2710/16334—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16311—Mardivirus, e.g. Gallid herpesvirus 2, Marek-like viruses, turkey HV
    • C12N2710/16361—Methods of inactivation or attenuation
    • C12N2710/16364—Methods of inactivation or attenuation by serial passage

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Microbiology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DK91203365.1T 1990-12-24 1991-12-20 Cellefri Mareks sygdomsvirus-vaccine DK0496135T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP90314297 1990-12-24

Publications (1)

Publication Number Publication Date
DK0496135T3 true DK0496135T3 (da) 1994-11-28

Family

ID=8205666

Family Applications (1)

Application Number Title Priority Date Filing Date
DK91203365.1T DK0496135T3 (da) 1990-12-24 1991-12-20 Cellefri Mareks sygdomsvirus-vaccine

Country Status (17)

Country Link
US (1) US5378467A (da)
EP (1) EP0496135B1 (da)
JP (1) JP3410744B2 (da)
KR (1) KR100187317B1 (da)
CN (1) CN1034554C (da)
AT (1) ATE109007T1 (da)
CA (1) CA2058386C (da)
DE (1) DE69103130T2 (da)
DK (1) DK0496135T3 (da)
DZ (1) DZ1550A1 (da)
ES (1) ES2061165T3 (da)
HU (2) HUT62200A (da)
IL (1) IL100386A (da)
MX (1) MX9102757A (da)
NZ (1) NZ241122A (da)
SA (1) SA92120430B1 (da)
ZA (1) ZA9110022B (da)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993023078A1 (en) * 1992-05-19 1993-11-25 Viktoria Alexeevna Lukina Vaccine for prophylaxis of marek disease of birds and method of its preparation
FR2719056B1 (fr) * 1994-04-20 1996-09-06 Rhone Merieux Herpesvirus transformés pour exprimer gD in vitro.
IL114501A (en) * 1994-07-14 1999-08-17 Akzo Nobel Nv Marek's disease virus vaccine
EP0703294A1 (en) * 1994-07-14 1996-03-27 Akzo Nobel N.V. Marek's disease virus vaccine
US5565202A (en) * 1994-08-12 1996-10-15 The United States Of America As Represented By The Secretary Of Agriculture Low enhancement serotype 2 vaccine for marek's disease
FR2857671B1 (fr) * 2003-07-18 2007-10-05 Centre Nat Rech Scient Nouveau procede de culture de keratinocytes et ses applications
ES2436317T3 (es) * 2010-05-07 2013-12-30 Deutsches Krebsforschungszentrum Parvovirus de roedor modificado capaz de propagarse y difundirse en gliomas humanos
CN111542337A (zh) 2017-12-20 2020-08-14 英特维特国际股份有限公司 用于细胞相关联的α疱疹病毒疫苗的改良稀释剂

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4160024A (en) * 1978-05-01 1979-07-03 Cornell Research Foundation, Inc. Marek's disease vaccine
US4895718A (en) * 1987-07-10 1990-01-23 The United States Of America, As Represented By The Secretary Of Agriculture Serotype 2 Marek's disease vaccine
JPS62212326A (ja) * 1987-09-14 1987-09-18 Gen Corp:Kk マレツク病２価生ワクチンとその製造方法

Also Published As

Publication number Publication date
HU914111D0 (en) 1992-03-30
EP0496135A3 (en) 1992-08-05
ATE109007T1 (de) 1994-08-15
DE69103130D1 (de) 1994-09-01
KR100187317B1 (ko) 1999-05-01
US5378467A (en) 1995-01-03
HUT62200A (en) 1993-04-28
IL100386A (en) 1995-07-31
HU210344A9 (en) 1995-04-28
JP3410744B2 (ja) 2003-05-26
EP0496135B1 (en) 1994-07-27
CA2058386A1 (en) 1992-06-25
DE69103130T2 (de) 1994-12-01
MX9102757A (es) 1992-07-01
NZ241122A (en) 1992-10-28
IL100386A0 (en) 1992-09-06
JPH04295433A (ja) 1992-10-20
ES2061165T3 (es) 1994-12-01
CN1064409A (zh) 1992-09-16
CN1034554C (zh) 1997-04-16
KR920011520A (ko) 1992-07-24
ZA9110022B (en) 1992-10-28
EP0496135A2 (en) 1992-07-29
CA2058386C (en) 2003-02-11
SA92120430B1 (ar) 2004-05-31
DZ1550A1 (fr) 2002-02-17

Similar Documents

Publication Publication Date Title
DE69016956D1 (de) Rekombinantes Truthahn-Herpesvirus und davon abgeleiteter Lebendimpfstoffvektor.
BR9102672A (pt) Composicao para exterminar microorganismos, composicao para exterminar virus envelopados, processo para exterminar microorganismos em ou sobre um hospedeiro e processo para exterminar virus envelopados em um ser humano ou animal de sangue quente, hospedeiro
DE3789399D1 (de) Herstellung von Vakkzinen gegen Hepatitis B-Virus.
MY103575A (en) Cannie coronavirus vaccine
DK0496135T3 (da) Cellefri Mareks sygdomsvirus-vaccine
FI890116A0 (fi) Icke-reverterande rna-virus.
GR3007856T3 (da)
WO1994000586A3 (fr) Mutants et vaccins du virus de la rhinotracheite infectieuse bovine
DK1087014T3 (da) Svinepestvirusvaccine og -diagnostik
MX9602256A (es) Vacuna contra la enfermedad de marek.
ATE18007T1 (de) Hepatitisimpfstoff.
DE59209310D1 (de) Impfstoffe auf Basis geänderter Boviner Herpesviren Typ 1
ATE3058T1 (de) Herpes-virus-impfstoff und seine herstellung.
TH12563EX (th) วีคซีนป้องกันไวรัสโรคมาเร็คชนิดปราศจากเซลล์
ATE310078T1 (de) Hühner-anäemie-virus mit geringer pathogenität
DK257887D0 (da) Fremgangsmaade til fremstilling af hbcag i gaer og plasmid til brug ved udoevelse af fremgangsmaaden
FI893346A0 (fi) Icke-reverterande rna-virus.
Bexendale Cell-free Marek's Disease virus vaccine
NO884921L (no) Fremgangsmaate for fremstilling av valpesyke-vaksine.
Von Ohlinger et al. Boar vaccination against Aujeszky's disease. 2. Communication: Virus excretion in nasal secretions and semen.